Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Femasys Inc (NQ: FEMY ) 1.110 -0.010 (-0.89%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 95,328 Open 1.130 Bid (Size) 1.110 (12) Ask (Size) 1.120 (5) Prev. Close 1.120 Today's Range 1.090 - 1.140 52wk Range 0.2479 - 4.750 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam June 27, 2024 Leading women’s reproductive health conference directly follows the company’s EU CE Mark approval for four of its products From Femasys Inc. Via GlobeNewswire Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher June 20, 2024 Via Benzinga Topics Stocks Exposures US Equities Performance YTD +9.90% +9.90% 1 Month -5.13% -5.13% 3 Month -12.60% -12.60% 6 Month +36.99% +36.99% 1 Year +192.72% +192.72% More News Read More 12 Health Care Stocks Moving In Thursday's Intraday Session June 20, 2024 Via Benzinga Gold Rises 1%; Accenture Shares Surge After Q3 Results June 20, 2024 Via Benzinga Deep Dive Into Femasys Stock: Analyst Perspectives (4 Ratings) June 20, 2024 Via Benzinga Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe June 20, 2024 From Femasys Inc. Via GlobeNewswire EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says June 17, 2024 Via Benzinga Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative May 17, 2024 From Femasys Inc. Via GlobeNewswire Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council May 16, 2024 From Femasys Inc. Via GlobeNewswire FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update May 09, 2024 From Femasys Inc. Via GlobeNewswire Femasys Expands Commercial Management Team with Addition of Experienced New Hires May 07, 2024 From Femasys Inc. Via GlobeNewswire Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives April 18, 2024 From Femasys Inc. Via GlobeNewswire FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023 March 28, 2024 Via InvestorPlace Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update March 28, 2024 From Femasys Inc. Via GlobeNewswire Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape March 21, 2024 From Femasys Inc. Via GlobeNewswire Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility March 20, 2024 From Femasys Inc. Via GlobeNewswire Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 March 13, 2024 From Femasys Inc. Via GlobeNewswire Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution March 06, 2024 From Femasys Inc. Via GlobeNewswire Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF February 28, 2024 From Femasys Inc. Via GlobeNewswire First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks February 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 07, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
